CEO Alain Moussy Expounds on the Complex Journey of Masitinib Development in Interview| Alain Moussy, CEO, AB Science SA. 00:10:00

Share On Facebook Share On Twitter

In this interview, CEO Alain Moussy provides comprehensive insights into the intricate development process of Masitinib, shedding light on the challenges, breakthroughs, and future prospects of this innovative pharmaceutical endeavor

Recent Videos